specialty medicine endocrinology incretin therapy

💉 Mounjaro 15 mg Injection | Tirzepatide | GIP/GLP-1 Therapy | Export Supplier Mounjaro 15 mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used in the management of Type 2 Diabetes Mellitus. It helps improve glycemic control by enhancing insulin secretion and regulating metabolic pathways under medical supervision. 🔹 Product Category Specialty Medicine (Endocrinology / Incretin Therapy) 🔹 Composition Tirzepatide 15 mg 🔹 Indications ✔ Type 2 Diabetes Mellitus ✔ Glycemic Control (as prescribed) ✔ Adjunct to diet & lifestyle management 🔹 Key Benefits ✔ Dual GIP & GLP-1 receptor action ✔ Supports HbA1c reduction ✔ Once-weekly dosing (as prescribed) ✔ Advanced incretin-based therapy 🔹 Dosage & Administration ✔ Subcutaneous injection ✔ Once weekly (per physician guidance) ✔ Dose escalation as per clinical protocol 🔹 Packaging ✔ Pre-filled Pen Device ✔ Export-Ready Packaging Available ✔ Cold-chain logistics required ✔ Bulk Supply Supported 🔹 Storage ✔ Refrigerated (2–8°C) ✔ Do not freeze ✔ Maintain cold-chain during transit 🔹 Certifications ✔ WHO-GMP Certified (as applicable) ✔ COA & regulatory documents available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Chicago, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Diabetes Care Products ✔ Endocrinology Medicines ✔ Oncology Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 📧 Email ✉️ sales@pacificmedicines.com